CIRCLE PHARMA, INC.

Profile

Company Names

CIRCLE PHARMA, INC.

Addresses

681 GATEWAY BLVD, 3RD FLOOR, SOUTH SAN FRANCISCO, CA 94080

681 GATEWAY BLVD., LGL, 3RD FLOOR, SOUTH SAN FRANCISCO, CA 94618

280 UTAH AVENUE, SUITE 100, SOUTH SAN FRANCISCO, CA 94080

280 UTAH AVENUE, SUITE 100, SAN FRANCISCO, CA 94080

Phone Numbers

650-392-0350

 

Entity Type:

CORPORATION

Industry:

OTHER, PHARMACEUTICALS

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$177,557,504.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2024-06-28 
$92,444,167.00 
$117,374,782.00 
$24,930,615.00 
Equity 
3
2021-06-15 
$66,304,990.00 
$66,304,990.00 
$0.00 
Equity 
2
2020-03-16 
$14,999,999.00 
$45,000,000.00 
$30,000,001.00 
Equity 
1
2016-09-06 
$3,808,348.00 
$6,047,554.00 
$2,239,206.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DOUGLAS 
 
CRAWFORD 
DIRECTOR
MISSION BAY CAPITAL, LLC   |  MCP BLOOM LLC   |  MCP FISKER LLC   |  DELPOR, INC.   |  ZEPHYRUS BIOSCIENCES, INC.   |  MISSION BAY CAPITAL II, L.P.   |  VIEWPOINT THERAPEUTICS, INC.   |  EPIODYNE, INC.   |  CIRCLE PHARMA, INC.   |  TANGIBLE SCIENCE, LLC   |  PHOTOSWITCH BIOSCIENCES, INC.   |  MITOKININ, INC.   |  INVENIO IMAGING, INC.   |  TANGIBLE SCIENCE, INC. (FKA TANGIBLE SCIENCE, LLC)   |  ALESSA THERAPEUTICS, INC.
DAVID 
 
EARP 
EXECUTIVE OFFICER, DIRECTOR
CIRCLE PHARMA, INC.
DAVID 
J. 
EARP 
EXECUTIVE OFFICER, DIRECTOR
CIRCLE PHARMA, INC.
JAMES 
 
EVANGELISTA 
DIRECTOR
CIRCLE PHARMA, INC.
MATTHEW 
 
JACOBSON 
DIRECTOR
OXFORD COUNTY TELEPHONE + TELEGRAPH CO   |  CIRCLE PHARMA, INC.   |  SKUID, INC.   |  APPBOY, INC.   |  GOOD BAD UGLY LLC   |  BRAZE, INC.   |  SMILE FAMILY, INC.   |  HIGHSPOT, INC.   |  NINE SQUARE THERAPEUTICS, INC.   |  NINE SQUARE THERAPEUTICS CORP
MATTHEW 
P. 
JACOBSON 
DIRECTOR
CIRCLE PHARMA, INC.
JOHN 
 
JOSEY 
DIRECTOR
PELOTON THERAPEUTICS, INC.   |  CIRCLE PHARMA, INC.   |  DAY ONE BIOPHARMACEUTICALS HOLDING CO LLC
STEPHEN 
 
KELSEY 
DIRECTOR
CIRCLE PHARMA, INC.
SCOTT 
R. 
LOKEY 
DIRECTOR
CIRCLE PHARMA, INC.
CAYLA 
 
MCEWEN 
EXECUTIVE OFFICER
CIRCLE PHARMA, INC.
WALTER 
 
MOOS 
DIRECTOR
CIRCLE PHARMA, INC.   |  VALITOR, INC.   |  PANDECT BIOVENTURES, L.P.
WALTER 
H. 
MOOS 
DIRECTOR
CIRCLE PHARMA, INC.
PAUL 
 
PARK 
EXECUTIVE OFFICER
GALTON MORTGAGE STRATEGIES ONSHORE FUND, L.P.   |  GALTON ONSHORE MORTGAGE RECOVERY FUND III, L.P.   |  GALTON ONSHORE MORTGAGE RECOVERY FUND IV, L.P.   |  UPFIT TRAINING, LLC   |  CIRCLE PHARMA, INC.
ELTON 
 
SATUSKY 
EXECUTIVE OFFICER
CIRCLE PHARMA, INC.   |  TRIFLO CARDIOVASCULAR INC   |  EMBOLINE INC   |  VITAL LABS, INC.
THILO 
 
SCHROEDER 
DIRECTOR
BLUEPRINT MEDICINES CORP   |  IMAGINAB, INC.   |  IDEAYA BIOSCIENCES, INC.   |  REVOLUTION MEDICINES, INC.   |  SILVERBACK THERAPEUTICS, INC.   |  CIRCLE PHARMA, INC.   |  ALTEROME THERAPEUTICS, INC.   |  NEXTECH VII ONCOLOGY SCSP   |  NEXTECH CROSSOVER I SCSP   |  NEXTECH VII CARRY SCSP   |  NEXTECH CROSSOVER I CARRY SCSP   |  NEXTECH VIII SCSP   |  STIPPLE BIO, INC.
PETER 
 
SVENNILSON 
DIRECTOR
FARALLON BIOSCIENCES, INC   |  NGM BIOPHARMACEUTICALS INC   |  COLUMN GROUP II, LP   |  ARAGON PHARMACEUTICALS, INC.   |  PTC THERAPEUTICS, INC.   |  IMMUNE DESIGN CORP.   |  COLUMN GROUP II, LP   |  COLUMN GROUP III-A, LP   |  COLUMN GROUP III, LP   |  CONSTELLATION PHARMACEUTICALS INC   |  CIRCLE PHARMA, INC.   |  CARMOT THERAPEUTICS INC.   |  COLUMN GROUP-NEURO, LP   |  COLUMN GROUP V, LP   |  COLUMN GROUP OPPORTUNITY III, LP   |  COLUMN GROUP SPV I, LP   |  COLUMN GROUP-NEURO II, LP   |  NGM BIO HOLDINGS, INC.   |  NEURONA THERAPEUTICS, INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-01-10
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-06-28 
2024-08-29
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-06-28 
2024-07-03
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-06-28 
2022-03-22
D/A
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2021-06-15 
2021-06-29
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2021-06-15 
2020-03-23
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-16 
2016-09-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-09-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#